Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1 + 1) compared with two primary doses and a booster (2 + 1) in UK infants: a multicentre, parallel group randomised controlled trial (Lancet Infectious Diseases, 2017)

(untitled) - Goldblatt, D; Southern, J; Andrews, N; Burbidge, P; Partington, J; Roalfe, L; Valente Pinto, M; Thalasselis, V; Plested, E; Richardson, H; Snape, M; Miller, E